CCL14



CCL14

T1TT1K2KK2T3TT3E4EE4S5SS5S6SS6S7SS7R8RR8G9GG9P10PP10Y11YY11H12HH12P13PP13S14SS14E15EE15C16CC16C17CC17F18FF18T19TT19Y20YY20T21TT21T22TT22Y23YY23K24KK24I25II25P26PP26R27RR27Q28QQ28R29RR29I30II30M31MM31D32DD32Y33YY33Y34YY34E35EE35T36TT36N37NN37S38SS38Q39QQ39C40CC40S41SS41K42KK42P43PP43G44GG44I45II45V46VV46F47FF47... and 27 more residue(s)...... and 27 more residue(s)

SMILES None
InChIKey None
Sequence TKTESSSRGPYHPSECCFTYTTYKIPRQRIMDYYETNSQCSKPGIVFITKRGHSVCTNPSDKWVQDYIKDMKEN

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections


No bioactivity data available.

CCL14

T1TT1K2KK2T3TT3E4EE4S5SS5S6SS6S7SS7R8RR8G9GG9P10PP10Y11YY11H12HH12P13PP13S14SS14E15EE15C16CC16C17CC17F18FF18T19TT19Y20YY20T21TT21T22TT22Y23YY23K24KK24I25II25P26PP26R27RR27Q28QQ28R29RR29I30II30M31MM31D32DD32Y33YY33Y34YY34E35EE35T36TT36N37NN37S38SS38Q39QQ39C40CC40S41SS41K42KK42P43PP43G44GG44I45II45V46VV46F47FF47... and 27 more residue(s)...... and 27 more residue(s)

Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections


Compound is not listed as a drug.